XCUR (Exicure, Inc.) Total Business Assets

Official company branding of Exicure (XCUR)

This chart of total assets for Exicure, Inc. (XCUR), valued at 15.06, reflects the dynamics of a company that has optimized its workforce down to a minimal core of scientists and transitioned to outsourcing. The business relies on its unique SNA platform, which secures partners through strict patent agreements, as well as a team of top geneticists motivated by stock options and the pursuit of breakthrough medical developments.

XCUR - Exicure Company Total Assets over the range 07/04/2022 - 10/29/2026
Signature product of Exicure Corp

The development of the SNA platform for precision skin and lung therapy requires significant resources, reflecting the scale of the technological foundation of Exicure, Inc. (XCUR). By analyzing the growth of total capital and liabilities, an investor can determine the total resources reverse-calculated via ROA, which allows for an assessment of asset utilization efficiency for business capitalization and confirms the company's financial stability.

Direct competitors

Tempus AI, Inc - Aggregate Asset Value|QGEN (Qiagen) - Company Total Assets|Total Business Assets IONS (Ionis Pharmaceuticals, Inc.)|Aggregate Company Assets Repligen Corp. (RGEN)|Avidity Corp - Total Business Assets|Company Total Assets CRSP (CRISPR Therapeutics AG)|Company Total Assets genedx.com WGS|Ultragenyx - Company Total Assets|Company Assets Beam Therapeutics Inc|SRPT (Sarepta Therapeutics Inc) - Cumulative Company Assets|Total Business Assets TWST|TXG (10x Genomics, Inc.) - Company Total Assets|intelliatx.com (NTLA) - Company Total Asset Base|Company Total Assets STOK|Cumulative Company Assets BioLife Solutions Inc BLFS|Wave Life Sciences Corp - Cumulative Company Assets|Company Total Assets Maze Therapeutics Corp MAZE|SION - Aggregate Company Assets|Aggregate Asset Value PRME (primemedicine.com)|TSHA: Company Total Assets|Company Assets uniQure NV (QURE)|Cumulative Company Assets MGTX|RGNX: Aggregate Asset Value|Company Total Assets SLDB|Company Total Asset Base ocugen.com|Aggregate Company Assets PacBio PACB|BNTC: Total Business Assets|Design Pharma - Company Total Assets|Rocket Corp (RCKT) - Cumulative Company Assets|FDMT (4D Molecular Therapeutics) - Cumulative Company Assets|LXEO - Company Total Asset Base|Cumulative Company Assets KRRO|Total Business Assets EDIT (Editas Medicine Inc)|Company Total Assets SLN|Cumulative Company Assets proqr.com PRQR|Codexis - Cumulative Company Assets|Company Total Assets sangamo.com SGMO|NAUT - Aggregate Company Assets|Aggregate Asset Value MGX (Metagenomi Inc.)|DTIL: Company Total Assets|Total Business Assets GBIO|Aggregate Company Assets Boundless Bio, Inc.|Total Business Assets IMNN (Celsion Corporation)|Company Total Assets PHIO|Company Total Assets mustangbio.com (MBIO)|Company Total Assets RNAZ (TransCode Therapeutics, Inc.)|Bionano Genomics Inc. (BNGO) - Company Assets|APDN: Cumulative Company Assets|BLUE (bluebirdbio.com) - Total Business Assets|IPA: Company Total Assets|OMGA - Company Total Asset Base|OMIC (Singular Genomics Systems Inc) - Company Total Assets|Cumulative Company Assets Regulus (RGLS)|Cumulative Company Assets SYRS (Syros Pharmaceuticals)|Company Total Assets telesisbio.com (TBIO)|Aggregate Company Assets TRACON Pharmaceuticals, Inc. TCON|Aggregate Asset Value UBX